FDA's New Chief Counsel Has Ties To Sharfstein In Baltimore
This article was originally published in The Gray Sheet
FDA has named Ralph Tyler, currently the insurance commissioner of Maryland, as the agency's new chief counsel
You may also be interested in...
Ralph Tyler is leaving FDA 18 months after becoming the agency's chief counsel.
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.